Maximal oral 5ASA ( DrugBank: - )
1 disease
| 告示番号 | 疾患名（ページ内リンク） | 臨床試験数 |
|---|---|---|
| 97 | 潰瘍性大腸炎 | 1 |
97. 潰瘍性大腸炎
臨床試験数 : 2,630 / 薬物数 : 1,459 - (DrugBank : 265) / 標的遺伝子数 : 144 - 標的パスウェイ数 : 202
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT01534312 (ClinicalTrials.gov) | January 2012 | 13/2/2012 | Casein Glycomacropeptide in Active Distal Ulcerative Colitis (Pilot Study) | Casein Glycomacropeptide in Active Distal Ulcerative Colitis (Pilot Study) | Colitis, Ulcerative;Inflammatory Bowel Diseases | Drug: CGMP protein;Drug: Maximal oral 5ASA | University of Aarhus | Arla Foods | Completed | 18 Years | N/A | Both | 24 | N/A | Denmark |